
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (07): 810-815.DOI: 10.12114/j.issn.1007-9572.2023.0343
Special Issue: 心血管最新文章合辑; 老年人群健康最新文章合辑
• Article • Previous Articles Next Articles
Received:2023-06-14
Revised:2023-09-11
Published:2024-03-05
Online:2023-12-19
Contact:
PENG Derong
通讯作者:
彭德荣
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0343
| 指标 | 低危组(n=5 930) | 中危组(n=1 804) | 高危组(n=2 085) | χ2值 | P值 | 趋势性检验P值 |
|---|---|---|---|---|---|---|
| 年龄 | 1 236.557 | <0.001 | <0.001 | |||
| 30~岁 | 561(9.5) | 4(0.2) | 36(1.7) | |||
| 40~岁 | 1 251(21.1) | 52(2.9) | 108(5.2) | |||
| 50~岁 | 1 522(25.7) | 342(19.0) | 454(21.8) | |||
| 60~岁 | 2 280(38.4) | 1 180(65.4) | 1 183(56.7) | |||
| 70~岁 | 316(5.3) | 226(12.5) | 304(14.6) | |||
| 男性 | 2 495(42.1) | 696(38.6) | 1 185(56.8) | 168.092 | <0.001 | <0.001 |
| 高中及以上学历 | 2 615(44.1) | 438(24.3) | 645(30.9) | 282.417 | <0.001 | <0.001 |
| 超重或肥胖 | 2 537(42.8) | 1 032(57.2) | 1 338(64.2) | 328.555 | <0.001 | <0.001 |
| 吸烟 | 881(14.9) | 303(16.8) | 742(35.6) | 431.602 | <0.001 | <0.001 |
| 饮酒 | 1 200(20.2) | 378(21.0) | 563(27.0) | 42.361 | <0.001 | <0.001 |
| 糖尿病 | 601(10.1) | 302(16.7) | 1 247(59.8) | 2 260.015 | <0.001 | <0.001 |
| 高血压 | 1 177(19.7) | 1 595(88.4) | 1 656(79.4) | 3 899.516 | <0.001 | <0.001 |
| 高三酰甘油血症 | 442(7.5) | 193(10.7) | 426(20.4) | 269.607 | <0.001 | <0.001 |
| 高总胆固醇血症 | 120(2.0) | 206(11.4) | 284(13.6) | 458.931 | <0.001 | <0.001 |
| 高低密度脂蛋白胆固醇血症 | 153(2.6) | 160(8.9) | 165(7.9) | 171.151 | <0.001 | <0.001 |
| 低高密度脂蛋白胆固醇血症 | 1 076(18.1) | 294(16.3) | 815(39.1) | 436.416 | <0.001 | <0.001 |
| 打鼾频率 | 110.051 | <0.001 | <0.001 | |||
| 不打鼾 | 4 640(78.2) | 1 237(68.6) | 1 406(67.4) | |||
| 轻度打鼾 | 668(11.3) | 307(17.0) | 354(17.0) | |||
| 中度打鼾 | 418(7.0) | 171(9.5) | 211(10.1) | |||
| 重度打鼾 | 204(3.4) | 89(4.9) | 114(5.5) |
Table 1 Correlation analysis of 10-year risk of ASCVD in middle-aged and elderly population in Shanghai
| 指标 | 低危组(n=5 930) | 中危组(n=1 804) | 高危组(n=2 085) | χ2值 | P值 | 趋势性检验P值 |
|---|---|---|---|---|---|---|
| 年龄 | 1 236.557 | <0.001 | <0.001 | |||
| 30~岁 | 561(9.5) | 4(0.2) | 36(1.7) | |||
| 40~岁 | 1 251(21.1) | 52(2.9) | 108(5.2) | |||
| 50~岁 | 1 522(25.7) | 342(19.0) | 454(21.8) | |||
| 60~岁 | 2 280(38.4) | 1 180(65.4) | 1 183(56.7) | |||
| 70~岁 | 316(5.3) | 226(12.5) | 304(14.6) | |||
| 男性 | 2 495(42.1) | 696(38.6) | 1 185(56.8) | 168.092 | <0.001 | <0.001 |
| 高中及以上学历 | 2 615(44.1) | 438(24.3) | 645(30.9) | 282.417 | <0.001 | <0.001 |
| 超重或肥胖 | 2 537(42.8) | 1 032(57.2) | 1 338(64.2) | 328.555 | <0.001 | <0.001 |
| 吸烟 | 881(14.9) | 303(16.8) | 742(35.6) | 431.602 | <0.001 | <0.001 |
| 饮酒 | 1 200(20.2) | 378(21.0) | 563(27.0) | 42.361 | <0.001 | <0.001 |
| 糖尿病 | 601(10.1) | 302(16.7) | 1 247(59.8) | 2 260.015 | <0.001 | <0.001 |
| 高血压 | 1 177(19.7) | 1 595(88.4) | 1 656(79.4) | 3 899.516 | <0.001 | <0.001 |
| 高三酰甘油血症 | 442(7.5) | 193(10.7) | 426(20.4) | 269.607 | <0.001 | <0.001 |
| 高总胆固醇血症 | 120(2.0) | 206(11.4) | 284(13.6) | 458.931 | <0.001 | <0.001 |
| 高低密度脂蛋白胆固醇血症 | 153(2.6) | 160(8.9) | 165(7.9) | 171.151 | <0.001 | <0.001 |
| 低高密度脂蛋白胆固醇血症 | 1 076(18.1) | 294(16.3) | 815(39.1) | 436.416 | <0.001 | <0.001 |
| 打鼾频率 | 110.051 | <0.001 | <0.001 | |||
| 不打鼾 | 4 640(78.2) | 1 237(68.6) | 1 406(67.4) | |||
| 轻度打鼾 | 668(11.3) | 307(17.0) | 354(17.0) | |||
| 中度打鼾 | 418(7.0) | 171(9.5) | 211(10.1) | |||
| 重度打鼾 | 204(3.4) | 89(4.9) | 114(5.5) |
| 变量 | 赋值 |
|---|---|
| 年龄 | 30~岁=1,40~岁=2,50~岁=3,60~岁=4,70~岁=5 |
| 性别 | 女=0,男=1 |
| 高血压 | 否=0,是=1 |
| 糖尿病 | 否=0,是=1 |
| 超重或肥胖 | 否=0,是=1 |
| 饮酒 | 否=0,是=1 |
| 高中及以上学历 | 否=0,是=1 |
| 吸烟 | 否=0,是=1 |
| 打鼾频率 | 不打鼾=0,轻度打鼾=1,中度打鼾=2,重度打鼾=3 |
| ASCVD 10年发病风险 | 低危=1,中危=2,高危=3 |
| 高三酰甘油血症 | 否=0,是=1 |
| 高总胆固醇血症 | 否=0,是=1 |
| 高低密度脂蛋白胆固醇血症 | 否=0,是=1 |
| 低高密度脂蛋白胆固醇血症 | 否=0,是=1 |
Table 2 Variable assignment
| 变量 | 赋值 |
|---|---|
| 年龄 | 30~岁=1,40~岁=2,50~岁=3,60~岁=4,70~岁=5 |
| 性别 | 女=0,男=1 |
| 高血压 | 否=0,是=1 |
| 糖尿病 | 否=0,是=1 |
| 超重或肥胖 | 否=0,是=1 |
| 饮酒 | 否=0,是=1 |
| 高中及以上学历 | 否=0,是=1 |
| 吸烟 | 否=0,是=1 |
| 打鼾频率 | 不打鼾=0,轻度打鼾=1,中度打鼾=2,重度打鼾=3 |
| ASCVD 10年发病风险 | 低危=1,中危=2,高危=3 |
| 高三酰甘油血症 | 否=0,是=1 |
| 高总胆固醇血症 | 否=0,是=1 |
| 高低密度脂蛋白胆固醇血症 | 否=0,是=1 |
| 低高密度脂蛋白胆固醇血症 | 否=0,是=1 |
| 项目 | 模型一 | 模型二 | 模型三 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | |
| 男性 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.333 | 0.563 | 1.24(0.87~1.76) | 0.656 | 0.418 | 1.27(0.89~1.80) | 2.097 | 0.148 | 1.40(0.94~2.08) |
| 中度打鼾 | 11.791 | 0.001 | 1.45(1.17~1.78) | 5.151 | 0.023 | 1.28(1.03~1.58) | 0.020 | 0.889 | 1.10(0.98~1.82) |
| 重度打鼾 | 68.246 | <0.001 | 1.96(1.67~2.30) | 56.513 | <0.001 | 1.94(1.65~2.29) | 6.567 | 0.010 | 1.28(1.05~1.56) |
| 女性 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.883 | 0.347 | 1.08(0.92~1.28) | 0.034 | 0.853 | 0.99(0.83~1.18) | 0.564 | 0.453 | 0.85(0.69~1.06) |
| 中度打鼾 | 10.168 | 0.001 | 1.48(1.15~1.89) | 4.258 | 0.039 | 1.31(1.07~1.60) | 3.969 | 0.056 | 1.08(0.92~1.28) |
| 重度打鼾 | 24.738 | <0.001 | 1.61(1.33~1.94) | 8.215 | 0.004 | 1.34(1.03~1.73) | 7.929 | 0.005 | 1.15(1.15~1.57) |
| 整体 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.784 | 0.356 | 1.36(0.99~1.86) | 2.348 | 0.137 | 1.33(0.95~1.53) | 3.073 | 0.080 | 1.18(0.83~1.35) |
| 中度打鼾 | 38.274 | <0.001 | 1.57(1.37~1.81) | 17.146 | <0.001 | 1.6(1.43~1.80) | 5.023 | 0.025 | 1.15(1.07~1.37) |
| 重度打鼾 | 41.685 | <0.001 | 1.71(1.41~2.07) | 27.068 | <0.001 | 1.63(1.35~1.99) | 9.741 | 0.002 | 1.50(1.19~1.88) |
Table 3 Logistic regression analysis of snoring frequency and risk of ASCVD in the next 10 years in middle-aged and elderly population in Shanghai
| 项目 | 模型一 | 模型二 | 模型三 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | Wald χ2值 | P值 | OR(95%CI) | |
| 男性 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.333 | 0.563 | 1.24(0.87~1.76) | 0.656 | 0.418 | 1.27(0.89~1.80) | 2.097 | 0.148 | 1.40(0.94~2.08) |
| 中度打鼾 | 11.791 | 0.001 | 1.45(1.17~1.78) | 5.151 | 0.023 | 1.28(1.03~1.58) | 0.020 | 0.889 | 1.10(0.98~1.82) |
| 重度打鼾 | 68.246 | <0.001 | 1.96(1.67~2.30) | 56.513 | <0.001 | 1.94(1.65~2.29) | 6.567 | 0.010 | 1.28(1.05~1.56) |
| 女性 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.883 | 0.347 | 1.08(0.92~1.28) | 0.034 | 0.853 | 0.99(0.83~1.18) | 0.564 | 0.453 | 0.85(0.69~1.06) |
| 中度打鼾 | 10.168 | 0.001 | 1.48(1.15~1.89) | 4.258 | 0.039 | 1.31(1.07~1.60) | 3.969 | 0.056 | 1.08(0.92~1.28) |
| 重度打鼾 | 24.738 | <0.001 | 1.61(1.33~1.94) | 8.215 | 0.004 | 1.34(1.03~1.73) | 7.929 | 0.005 | 1.15(1.15~1.57) |
| 整体 | |||||||||
| 不打鼾 | — | — | 1.00 | — | — | 1.00 | — | — | 1.00 |
| 轻度打鼾 | 0.784 | 0.356 | 1.36(0.99~1.86) | 2.348 | 0.137 | 1.33(0.95~1.53) | 3.073 | 0.080 | 1.18(0.83~1.35) |
| 中度打鼾 | 38.274 | <0.001 | 1.57(1.37~1.81) | 17.146 | <0.001 | 1.6(1.43~1.80) | 5.023 | 0.025 | 1.15(1.07~1.37) |
| 重度打鼾 | 41.685 | <0.001 | 1.71(1.41~2.07) | 27.068 | <0.001 | 1.63(1.35~1.99) | 9.741 | 0.002 | 1.50(1.19~1.88) |
| 项目 | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|
| 高三酰甘油血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 0.174 | 0.677 | 0.67(0.59~1.12) |
| 中度打鼾 | 2.678 | 0.102 | 0.85(0.69~1.03) |
| 重度打鼾 | 7.197 | 0.007 | 1.32(1.07~1.64) |
| 高总胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 0.125 | 0.724 | 0.66(0.50~1.02) |
| 中度打鼾 | 3.060 | 0.080 | 1.21(0.83~1.77) |
| 重度打鼾 | 11.590 | 0.001 | 1.56(1.21~2.01) |
| 高低密度脂蛋白胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 4.416 | 0.065 | 0.88(0.66~1.18) |
| 中度打鼾 | 7.113 | 0.008 | 1.39(1.03~1.87) |
| 重度打鼾 | 8.561 | 0.033 | 1.49(1.01~2.21) |
| 低高密度脂蛋白胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 3.698 | 0.054 | 0.96(0.75~1.22) |
| 中度打鼾 | 8.561 | 0.003 | 1.26(1.06~1.49) |
| 重度打鼾 | 6.438 | 0.011 | 1.14(1.00~1.31) |
Table 4 Logistic regression analysis of the correlation between snoring frequency and ASCVD risk factors in middle-aged and elderly population in Shanghai
| 项目 | Wald χ2值 | P值 | OR(95%CI) |
|---|---|---|---|
| 高三酰甘油血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 0.174 | 0.677 | 0.67(0.59~1.12) |
| 中度打鼾 | 2.678 | 0.102 | 0.85(0.69~1.03) |
| 重度打鼾 | 7.197 | 0.007 | 1.32(1.07~1.64) |
| 高总胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 0.125 | 0.724 | 0.66(0.50~1.02) |
| 中度打鼾 | 3.060 | 0.080 | 1.21(0.83~1.77) |
| 重度打鼾 | 11.590 | 0.001 | 1.56(1.21~2.01) |
| 高低密度脂蛋白胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 4.416 | 0.065 | 0.88(0.66~1.18) |
| 中度打鼾 | 7.113 | 0.008 | 1.39(1.03~1.87) |
| 重度打鼾 | 8.561 | 0.033 | 1.49(1.01~2.21) |
| 低高密度脂蛋白胆固醇血症 | |||
| 不打鼾 | — | — | 1.00 |
| 轻度打鼾 | 3.698 | 0.054 | 0.96(0.75~1.22) |
| 中度打鼾 | 8.561 | 0.003 | 1.26(1.06~1.49) |
| 重度打鼾 | 6.438 | 0.011 | 1.14(1.00~1.31) |
| [1] | |
| [2] |
潘丽娜,高云,刘虹宏,等. 基于《中国心血管病预防指南2017》的中青年高血压患者ASCVD危险评估及分层分析[J]. 中国循证心血管医学杂志,2022,14(4):484-487. DOI:10.3969/j.issn.1674-4055.2022.04.25.
|
| [3] |
|
| [4] |
|
| [5] |
谢开婿,王春梅,陈玲琍,等. 睡眠打鼾与浙江省成年人高血压患病关联的研究[J]. 中华流行病学杂志,2020,41(5):722-726. DOI:10.3760/cma.j.cn112338-20190814-00596.
|
| [6] |
胡晶晶,乔鹏,赵佳,等. 上海市杨浦区居民打鼾与糖尿病的相关性调查研究[J]. 中国预防医学杂志,2021,22(1):37-42. DOI:10.16506/j.1009-6639.2021.01.008.
|
| [7] |
|
| [8] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2020年版)[J]. 国际内分泌代谢杂志,2021,41(5):482-548.
|
| [9] |
《中国高血压防治指南》修订委员会. 中国高血压防治指南2018年修订版[J]. 心脑血管病防治,2019,19(1):1-44. DOI:10.3969/j.issn.1009-816X.2019.01.001.
|
| [10] |
诸骏仁,高润霖,赵水平,等. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志,2016,31(10):937-953.
|
| [11] |
|
| [12] |
李岩. 北京社区居民打鼾与颈动脉粥样硬化关系的调查研究[J]. 中华疾病控制杂志,2013,17(8):702-705.
|
| [13] |
孙海丽,秦彦文,魏永祥. 阻塞性睡眠呼吸暂停与动脉粥样硬化关系的研究进展[J]. 临床耳鼻咽喉头颈外科杂志,2020,34(10):958-960. DOI:10.13201/j.issn.2096-7993.2020.10.023.
|
| [14] |
|
| [15] |
刘玲娇,林燕,余湘尤,等. TG/HDL-c与职业人群ASCVD风险的相关性分析[J]. 重庆医学,2021,50(11):1891-1895. DOI:10.3969/j.issn.1671-8348.2021.11.021.
|
| [16] |
|
| [17] |
夏艳杰. 打鼾与心血管病及其代谢性危险因素的关系研究[D]. 北京:北京协和医学院,2019.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [1] | YAN Wen, ZHANG Hanzhi, JIN Hua, QIAN Jie, YU Dehua. Study on the Diagnosis and Treatment Capacity for Depressive Disorders in Community Health Service Institutions in Shanghai [J]. Chinese General Practice, 2026, 29(20): 2790-2799. |
| [2] | JIAN Yingchun, ZENG Yongqin, ZHANG Haiping, WANG Zhengdi, AN Ke, YAN Rui. Recent Advances in Mitochondrial Dysfunction in Chronic Metabolic Diseases [J]. Chinese General Practice, 2026, 29(18): 2577-2584. |
| [3] | LIU Daiyue, LIU Xincan, LAN Zhenzhen. Research Progress on Postprandial Hyperlipidemia and Its Therapeutic Approaches [J]. Chinese General Practice, 2026, 29(18): 2546-2553. |
| [4] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [5] | LIU Tianyuan, SANG Wanyue, PENG Jiping, CHENG Siyi, HUANG Yiyi, LI Ouwen, JIANG Hong, ZHOU Xiaoya. Correlation Analysis between Neurofilament Light Chain and the Risk of Left Ventricular Hypertrophy in Patients with Nocturnal Hypertension [J]. Chinese General Practice, 2026, 29(15): 2014-2021. |
| [6] | YU Jie, WU Chunxiang, CAI Ning, ZHU Xiaoxia, SHEN Li. Study on Multidimensional Healthcare-seeking Behavior Patterns and Influencing Factors in Diabetic Patients [J]. Chinese General Practice, 2026, 29(14): 1827-1839. |
| [7] | ZHANG Yaping, ZHAO Xuhao, PANG Ting, HE Xindi, YUAN Changzheng, WEN Xu, LIU Zuyun, XU Xin. Association between Health Physical Fitness and Successful Aging among Middle-aged and Elderly Adults in the Community [J]. Chinese General Practice, 2026, 29(13): 1706-1712. |
| [8] | YUAN Weixia, AO Panpan, MA Yun, WU Fengfu, XU Facui, YU Juan, ZENG Qun, WEI Shaofeng, YUAN Lijia. The Predictive Value of Age-adjusted Charlson Comorbidity Index for Sarcopenia in Older Adults [J]. Chinese General Practice, 2026, 29(13): 1673-1681. |
| [9] | ZHANG Hanzhi, JIN Hua, MA Le, SHI Ling, CHEN Chen, HUAN Hongmei, YU Dehua. Analysis of the Quality of Diagnosis and Treatment of Osteoporosis in Shanghai Community Health Service Institutions [J]. Chinese General Practice, 2026, 29(12): 1548-1557. |
| [10] | LIU Haiyan, WANG Haitang, DU Zhaohui. The Evaluation Indicators for the High-quality Development of Family Doctor Contract Services Using the Delphi Method [J]. Chinese General Practice, 2026, 29(10): 1277-1285. |
| [11] | YANG Xu, FAN Jieting, SONG Hongyan, FENG Panpan, HAO Jingyu, YAO Mi. Risk Assessment and Communication Strategies for Cardiovascular Diseases in Primary Care [J]. Chinese General Practice, 2026, 29(10): 1294-1299. |
| [12] | SUN Qinyu, DENG Yifan, YANG Tianxiao, FANG Zhen, JI Jun, HE Shenghu, ZHANG Jing. Clinical Study of HbA1c/ApoA-1, TyG-BMI and Their Combination to Predict the Severity of Coronary Artery Calcification [J]. Chinese General Practice, 2026, 29(09): 1137-1145. |
| [13] | PEI Zhiyi, ZHANG Xiaoxin, LIN Jiayi, ZHANG Xiangyi, KANG Xiaofeng. Systematic Review of the Quality and Application of Patient Decision Aids in Cardiovascular Disease Based on IPDAS 4.0 Criteria [J]. Chinese General Practice, 2026, 29(07): 945-952. |
| [14] | YANG Juan, LIU Shan, LI Fei, MENG Haodong, QIAO Hui, XIE Yongxin. Dynamic Monitoring and Analysis of Influencing Factors of Health Shocks in Rural Middle Aged and Elderly People in Ningxia: Empirical Research Based on 14 Years and Four Periods of Follow-up Data before and after Poverty Alleviation [J]. Chinese General Practice, 2026, 29(07): 914-921. |
| [15] | FAN Zhuanzhuan, LI Wenting, MA Guoliang. Relationship between the Chinese Visceral Adipose Index and Cardiovascular Disease in Postmenopausal Women: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(02): 180-187. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||